KCR Video Diary

#HumanBehindEveryNumber – KCR’s patient-centric project about patients in clinical trials

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

Who is #HumanBehindEveryNumber? (trailer)

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

PCT 2016 KCR CEO on patients and big data

KCR’s CEO, Mike Jagielski, talks about the state of clinical trials from patient-centricity to big data.

Latest resources

#HumanBehindEveryNumber – KCR’s patient-centric project about patients in clinical trials

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

Who is #HumanBehindEveryNumber? (trailer)

Patient-centricity has recently been a key word in the healthcare and drug development industry. KCR, a Contract Research Organization (CRO), is introducing a new project which is solely based on a patient-centric approach: #HumanBehindEveryNumber.

Developing Global Solutions for Product Safety - Recent Changes in EU Requirements and New Directions in PV Globalisation

Over the past 20 years, the level of globalisation in the pharmaceutical industry increased significantly for both innovative and generic drugs. International cooperation between regulatory bodies and the harmonisation of regulatory requirements are key elements supporting the effective development of medicines, wide access to advanced therapies and ensuring sufficient safety oversight.

Patient Communities for Rare Diseases

Rare diseases might be life threatening. How rare diseases communities might help patients and their caregivers to be better informed and engaged in their health outcomes?

Placebo Controlled Designs. Ethical Approaches

Despite the continuous development of new treatments, availability of efficient and safe methods remains a great unmet need. This term, ‘methods’, refers to the vast range of approaches to chemical and biologic medications, cell-based therapies, medical devices, psychotherapy and so on. Testing new procedures against placebo is thought to provide the most reliable data on the value of a new solution.

Challenges in Medical Coding - Concomitant Medication Therapy Data in Clinical Trials

Clinical trials are intended to prove or disprove a hypothesis set in the study protocol. For this reason, the quality of captured data plays an important role in the study outcome. From a Data Management (DM) perspective, the aim of the clinical study is to achieve clean, complete and consistent clinical data.

Case Study: Start-up Process

Start-up process at KCR is designed to set up the Electronic Data Capture (EDC) tool within a maximum of 12 weeks.

Case Study: Conduct Process

The conduct process at KCR ensures accurate prediction, prevention and dependable reaction on the data collected within a timely manner.